Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasso Apostolopoulos

Showing results (11-20 of 382) with videos related to

Pageof 39
Sort By:
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 18, 2018
Editorial: Multiple Sclerosis: Pathogenesis and TherapeuticsMaria Katsara, Vasso Apostolopoulos
Maturitas|February 13, 2021
Is COVID-19 the worst pandemic?Jack Feehan, Vasso Apostolopoulos
Inflammation|April 6, 2019
Pro-inflammatory S100A9 Protein: a Double-Edged Sword in Cancer?Vahid Bagheri, Vasso Apostolopoulos
Current Medicinal Chemistry|June 25, 2005
Insights into peptide-based vaccine design for cancer immunotherapyEliada Lazoura, Vasso Apostolopoulos
Brain Sciences|November 3, 2020
Advances in Multiple Sclerosis Research-Series IVasso Apostolopoulos, John Matsoukas
Expert Review of Vaccines|June 4, 2010
Methods to measure vaccine immunityVasso Apostolopoulos, Francesco M Marincola
Expert Review of Vaccines|February 21, 2022
Global impact of delta plus variant and vaccinationVivek P Chavda, Vasso Apostolopoulos
Maturitas|November 27, 2021
Reply to the letter 'Mucormycosis and black fungus: Breaking the myth'Vivek P Chavda, Vasso Apostolopoulos
Expert Review of Vaccines|September 5, 2008
Strategies used for MUC1 immunotherapy: preclinical studiesChoon-Kit Tang, Vasso Apostolopoulos
Expert Review of Vaccines|September 3, 2009
Development of more efficient and effective DNA vaccinesVasso Apostolopoulos, David B Weiner
Pageof 39

Showing results (11-20 of 382) with videos related to

Sort By:
Pageof 39
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 18, 2018
Editorial: Multiple Sclerosis: Pathogenesis and TherapeuticsMaria Katsara, Vasso Apostolopoulos
Maturitas|February 13, 2021
Is COVID-19 the worst pandemic?Jack Feehan, Vasso Apostolopoulos
Inflammation|April 6, 2019
Pro-inflammatory S100A9 Protein: a Double-Edged Sword in Cancer?Vahid Bagheri, Vasso Apostolopoulos
Current Medicinal Chemistry|June 25, 2005
Insights into peptide-based vaccine design for cancer immunotherapyEliada Lazoura, Vasso Apostolopoulos
Brain Sciences|November 3, 2020
Advances in Multiple Sclerosis Research-Series IVasso Apostolopoulos, John Matsoukas
Expert Review of Vaccines|June 4, 2010
Methods to measure vaccine immunityVasso Apostolopoulos, Francesco M Marincola
Expert Review of Vaccines|February 21, 2022
Global impact of delta plus variant and vaccinationVivek P Chavda, Vasso Apostolopoulos
Maturitas|November 27, 2021
Reply to the letter 'Mucormycosis and black fungus: Breaking the myth'Vivek P Chavda, Vasso Apostolopoulos
Expert Review of Vaccines|September 5, 2008
Strategies used for MUC1 immunotherapy: preclinical studiesChoon-Kit Tang, Vasso Apostolopoulos
Expert Review of Vaccines|September 3, 2009
Development of more efficient and effective DNA vaccinesVasso Apostolopoulos, David B Weiner
Pageof 39